BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 25358521)

  • 21. Changing epidemiology of candidemia in a medical center in middle Taiwan.
    Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.
    Toda M; Williams SR; Berkow EL; Farley MM; Harrison LH; Bonner L; Marceaux KM; Hollick R; Zhang AY; Schaffner W; Lockhart SR; Jackson BR; Vallabhaneni S
    MMWR Surveill Summ; 2019 Sep; 68(8):1-15. PubMed ID: 31557145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.
    Aguilar G; Delgado C; Corrales I; Izquierdo A; Gracia E; Moreno T; Romero E; Ferrando C; Carbonell JA; Borrás R; Navarro D; Belda FJ
    BMC Res Notes; 2015 Sep; 8():491. PubMed ID: 26415526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
    Marr KA; Seidel K; White TC; Bowden RA
    J Infect Dis; 2000 Jan; 181(1):309-16. PubMed ID: 10608780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
    Davis SL; Vazquez JA; McKinnon PS
    Ann Pharmacother; 2007 Apr; 41(4):568-73. PubMed ID: 17374623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
    Eggimann P; Francioli P; Bille J; Schneider R; Wu MM; Chapuis G; Chiolero R; Pannatier A; Schilling J; Geroulanos S; Glauser MP; Calandra T
    Crit Care Med; 1999 Jun; 27(6):1066-72. PubMed ID: 10397206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study.
    Torres HA; Kontoyiannis DP; Rolston KV
    Support Care Cancer; 2004 Jul; 12(7):511-6. PubMed ID: 14986077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
    Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt.
    Hegazi M; Abdelkader A; Zaki M; El-Deek B
    J Infect Dev Ctries; 2014 May; 8(5):624-34. PubMed ID: 24820467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-center retrospective study of the incidence of, and risk factors for, non-C. albicans invasive candidiasis in hospitalized patients in China.
    Wang L; Tong Z; Wang Z; Xu L; Wu Y; Liu Y; Wu L
    Med Mycol; 2014 Feb; 52(2):115-22. PubMed ID: 24626056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
    Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
    Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
    Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
    Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence, presentation and treatment of candidemia.
    Mikulska M; Del Bono V; Ratto S; Viscoli C
    Expert Rev Clin Immunol; 2012 Nov; 8(8):755-65. PubMed ID: 23167687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.
    Wu PF; Liu WL; Hsieh MH; Hii IM; Lee YL; Lin YT; Ho MW; Liu CE; Chen YH; Wang FD
    Emerg Microbes Infect; 2017 Oct; 6(10):e87. PubMed ID: 29018251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
    Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
    Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species.
    Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Manolopoulou P; Spiliopoulou I; Vrettos T; Dodou V; Filos KS; Anastassiou ED; Marangos M; Christofidou M
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):227-32. PubMed ID: 25175179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for fluconazole-resistant candidemia.
    Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Aznar-Martín J; Cisneros JM; Ortiz-Leyba C
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3149-54. PubMed ID: 20498325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.